These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11400939)
1. Combined use of genetic sonography and maternal serum triple-marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years. DeVore GR; Romero R J Ultrasound Med; 2001 Jun; 20(6):645-54. PubMed ID: 11400939 [TBL] [Abstract][Full Text] [Related]
2. Genetic sonography: an option for women of advanced maternal age with negative triple-marker maternal serum screening results. DeVore GR; Romero R J Ultrasound Med; 2003 Nov; 22(11):1191-9. PubMed ID: 14620890 [TBL] [Abstract][Full Text] [Related]
3. Is genetic ultrasound cost-effective? DeVore GR Semin Perinatol; 2003 Apr; 27(2):173-82. PubMed ID: 12769203 [TBL] [Abstract][Full Text] [Related]
4. Genetic sonography: a cost-effective method for evaluating women 35 years and older who decline genetic amniocentesis. DeVore GR; Romero R J Ultrasound Med; 2002 Jan; 21(1):5-13. PubMed ID: 11794403 [TBL] [Abstract][Full Text] [Related]
5. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related]
6. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
7. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Vintzileos AM; Campbell WA; Rodis JF; Guzman ER; Smulian JC; Knuppel RA Obstet Gynecol; 1996 Jun; 87(6):948-52. PubMed ID: 8649704 [TBL] [Abstract][Full Text] [Related]
9. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses? Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012 [TBL] [Abstract][Full Text] [Related]
10. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome. Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756 [TBL] [Abstract][Full Text] [Related]
11. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21. Vintzileos AM; Guzman ER; Smulian JC; Day-Salvatore DL; Knuppel RA Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1045-8. PubMed ID: 10561615 [TBL] [Abstract][Full Text] [Related]
14. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography? Sullivan A; Giudice T; Vavelidis F; Thiagarajah S Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666 [TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience. Spencer K; Nicolaides KH BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267 [TBL] [Abstract][Full Text] [Related]
16. Triple-marker prenatal screening program for chromosomal defects. Kazerouni NN; Currier B; Malm L; Riggle S; Hodgkinson C; Smith S; Tempelis C; Lorey F; Davis A; Jelliffe-Pawlowski L; Walton-Haynes L; Roberson M Obstet Gynecol; 2009 Jul; 114(1):50-58. PubMed ID: 19546758 [TBL] [Abstract][Full Text] [Related]
17. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis. DeVore GR; Alfi O Obstet Gynecol; 1995 Mar; 85(3):378-86. PubMed ID: 7862376 [TBL] [Abstract][Full Text] [Related]
18. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities]. Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119 [TBL] [Abstract][Full Text] [Related]
19. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Spencer K Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723 [TBL] [Abstract][Full Text] [Related]
20. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age. Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]